CN1305816A - Medicine for treating diabetes - Google Patents
Medicine for treating diabetes Download PDFInfo
- Publication number
- CN1305816A CN1305816A CN 00100178 CN00100178A CN1305816A CN 1305816 A CN1305816 A CN 1305816A CN 00100178 CN00100178 CN 00100178 CN 00100178 A CN00100178 A CN 00100178A CN 1305816 A CN1305816 A CN 1305816A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- fructus
- glibenclamide
- diabetes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
A medicine for treating diabetes is prepared from glibenclamide and 7 Chinese-medicinal materials including astragalus root, wolflberry fruit, dogwood fruit, rehmannia root, etc. Its advantages include high effective rate, low poison and no generation of drug resistance.
Description
The present invention relates to a kind of medicine, particularly a kind of medicine for the treatment of diabetes.This medicine trade name can be lowering blood sugar and preventing thirst happy (capsule).
The disease that diabetes are that a kind of sickness rate height, the course of disease are long, hazardness is big, are difficult to eradicate.Existing medicine is " diabetes pill " of Guangzhou No.1 Chinese Pharmacy Factory production particularly, its component is: medicines such as the Radix Astragali, Radix Rehmanniae, Radix Trichosanthis, Radix Puerariae add the Western medicine glibenclamide and form, " diabetes pill " is mainly used in the treatment type, this diabetes there is certain curative effect, but its effective percentage to type has side effect such as diarrhea, hypoglycemia, infringement liver after only reaching the 50-70% clothes, and clothes have drug resistance for a long time.
It is a kind of to type effective percentage height that purpose of the present invention will provide exactly, and Chinese medicine and western medicine is difficult for forming the medicine of drug-fast treatment diabetes in conjunction with attenuation synergistic.
The object of the present invention is achieved like this: its component of medicine provided by the present invention is mainly: the Radix Astragali, Fructus Lycii, Ramulus Euonymi, Fructus Corni, Radix Malvae, the Radix Rehmanniae, Radix Rehmanniae Preparata, glibenclamide, vitamin B
1In a little components, also can add: Rhizoma Atractylodis, Radix Puerariae, Radix Scrophulariae, Radix Salviae Miltiorrhizae, Rhizoma Dioscoreae, Fructus Schisandrae Chinensis, Cortex Cinnamomi, Poria, Rhizoma Alismatis.
Chinese medicine is pressed the glibenclamide (every content) 700 that per kilogram Chinese medicine adds 2.5mg through cleaning, oven dry, sterilization, grinding and processing powdered, in the sterilizing room inner packing, adorns 2000 of 0.5g the capsules, (vitamin B that adds pulverizing simultaneously for every kilogram
11000 of sheets).
The function of this medicine is: reinforcing the spleen and regulating the stomach, benefiting qi and nourishing yin, tonifying YANG, blood circulation promoting and blood stasis dispelling, lowering blood sugar and preventing thirst
Cure mainly: secondary type type and complication thereof have the auxiliary treatment effect to cardiovascular and cerebrovascular disease and peripheral nerve pain and essential diabetes.
Specification and packing: can be: the 0.5g/ grain, per 100 is 1 bag.
Usage and consumption: every day three times, each 4-6 grain, take 15-30 minute ante cibum.(every of this medicine contains 0.35 of glibenclamide, obeys 4 at every turn, closes 1.4 and contains 3.5mg, as obey 6, and close 2.1 and contain 5.25 milligrams, contain 6.3 3 times every day and contain 15.75mg, according to pharmacological action, cure mainly, usage, consumption do not exceed 20mg every day, can not produce any toxic and side effects.Vitamin B
1The each clothes of sheet 4 capsules contain 20mg, obey 6 and contain 30mg, meet human body normal demand amount.
Taboo: the high fat of period in a medicine fasting, high sugar food, quit smoking spill, the careful usefulness of anemia of pregnant woman, child forbidding.
Store: shady and cool dry place.The characteristics of this medicine are:
1. the many merits of herbal species become the encapsulated composition height that contains than water decoction of powder.
2. Chinese medicine is joined the side effect that Western medicine is made capsule effectively control for oral administration Western medicine.
3. the usefulness of dual function can effectively be brought into play and strengthen to Chinese-western medicine preparation, can control liver to separating the generation of drug metabolizing enzyme, is difficult for forming Drug resistance.
4. Chinese medicine contains more effective and composition; trace element and vitamin etc. are through the test of multiple compatibility; thousands of routine patients' contrast is used; the compatibility of this component and content is used can reach 90-96% to this class patient obvious effective rate; the healing number is also not within minority, can play significant protective effect to the internal organs of patient body inside.
5. contain more, significant blood sugar lowering thing and saccharide, Chinese medicine and western medicine use in conjunction in the Chinese medicine, have dual regulation.
6. this medicine effective percentage height, the development of may command diabetes, attenuation synergistic, no hypoglycemic reaction, the many internal organs of protection health are difficult for forming drug resistance, price is low, be a kind ofly test, just, honest and clean medicine.
The clinical trial situation: recent decades, medicine of the present invention reached good effect to the treatment of type by thousands of routine patients' clinical practice.
Below provide three embodiment and further specify the present invention:
Embodiment one:
Prescription: the Radix Astragali, Fructus Lycii, Ramulus Euonymi, Fructus Corni, Radix Malvae, the Radix Rehmanniae, Radix Rehmanniae Preparata, glibenclamide.
Embodiment two: the Radix Astragali, Fructus Lycii, Ramulus Euonymi, Fructus Corni, Radix Malvae, the Radix Rehmanniae, Radix Rehmanniae Preparata, Rhizoma Atractylodis, Radix Puerariae, Radix Scrophulariae, Radix Salviae Miltiorrhizae, Rhizoma Dioscoreae, Fructus Schisandrae Chinensis, Cortex Cinnamomi, Poria, Rhizoma Alismatis, glibenclamide, vitamin B
1
Embodiment three:
Prescription: Radix Rehmanniae 400g, Radix Rehmanniae Preparata 400g, Fructus Corni 400g, Rhizoma Atractylodis 300g, Radix Puerariae 400g, Radix Scrophulariae 400g, FRUCTUS LYCII BARBARI 400g, Radix Salviae Miltiorrhizae 300g, Ramulus Euonymi 300g, Radix Astragali 1000g, RHIIZOMA DIOSCOREAE frOm Henan of China 400g, Fructus Schisandrae Chinensis 300g, Cortex Cinnamomi 50g, Radix Malvae 300g, Poria 300g, Rhizoma Alismatis 300g, glibenclamide 3985 (2.5mg/ sheet), vitamin Bs
15950
Method for making: Chinese medicine is through cleaning, oven dry, detoxicating, grinding and processing powdered, presses 700 of the glibenclamides (every content) that per kilogram Chinese medicine adds 2.5mg, in the sterilizing room inner packing, and 2000 of every kilogram of dress 0.5g capsules, (vitamin B that adds pulverizing simultaneously
11000 of sheets).
Claims (3)
1. a medicine for the treatment of diabetes is characterized in that its prescription is: the Radix Astragali, Fructus Lycii, Ramulus Euonymi, Fructus Corni, Radix Malvae, the Radix Rehmanniae, Radix Rehmanniae Preparata, glibenclamide
2. according to the medicine of the described treatment diabetes of claim 1, it is characterized in that its prescription is: the Radix Astragali, Fructus Lycii, Ramulus Euonymi, Fructus Corni, Radix Malvae, the Radix Rehmanniae, Radix Rehmanniae Preparata, Rhizoma Atractylodis, Radix Puerariae, Radix Scrophulariae, Radix Salviae Miltiorrhizae, Rhizoma Dioscoreae, Fructus Schisandrae Chinensis, Cortex Cinnamomi, Poria, Rhizoma Alismatis, glibenclamide, vitamin B
1
3. according to claim, the medicine of 2 described treatment diabetes is characterized in that its prescription is: Radix Rehmanniae 400g, Radix Rehmanniae Preparata 400g, Fructus Corni 400g, Rhizoma Atractylodis 300g, Radix Puerariae 400g, Radix Scrophulariae 400g, FRUCTUS LYCII BARBARI 400g, Radix Salviae Miltiorrhizae 300g, Ramulus Euonymi 300g, Radix Astragali 1000g, RHIIZOMA DIOSCOREAE frOm Henan of China 400g, Fructus Schisandrae Chinensis 300g, Cortex Cinnamomi 50g, Radix Malvae 300g, Poria 300g, Rhizoma Alismatis 300g, glibenclamide 3985 (2.5mg/ sheet), vitamin Bs
15950.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00100178 CN1305816A (en) | 2000-01-17 | 2000-01-17 | Medicine for treating diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00100178 CN1305816A (en) | 2000-01-17 | 2000-01-17 | Medicine for treating diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1305816A true CN1305816A (en) | 2001-08-01 |
Family
ID=4575293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00100178 Pending CN1305816A (en) | 2000-01-17 | 2000-01-17 | Medicine for treating diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1305816A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102273621A (en) * | 2010-06-09 | 2011-12-14 | 苏州润新生物科技有限公司 | Food or health-care food for preventing and treating diabetes mellitus |
| CN103599383A (en) * | 2013-10-25 | 2014-02-26 | 李孔琳 | Traditional Chinese medicine formula for diabetes |
| CN103599386A (en) * | 2013-10-28 | 2014-02-26 | 陈维娜 | Traditional Chinese medicinal composition for treating diabetes |
| CN103599382A (en) * | 2013-10-25 | 2014-02-26 | 陈维娜 | Traditional Chinese medicine for treating diabetes accompanied with fatty liver and hypertension complications |
| CN103599385A (en) * | 2013-10-28 | 2014-02-26 | 陈维娜 | Traditional Chinese medicinal composition for treating hyperglycemia |
| CN103599384A (en) * | 2013-10-28 | 2014-02-26 | 陈维娜 | Traditional Chinese medicinal preparation for treating hyperglycemia |
| CN103599381A (en) * | 2013-10-23 | 2014-02-26 | 陈维娜 | Traditional Chinese medicine for treating diabetes |
| CN103656076A (en) * | 2013-12-18 | 2014-03-26 | 南昌大学 | Probiotics and Chinese herbal medicine compound preparation with hypoglycemic function |
| CN104740085A (en) * | 2015-04-19 | 2015-07-01 | 王跃进 | Method for producing blood glucose-reducing soft capsules by use of large dosage of dried rehamnnia root |
-
2000
- 2000-01-17 CN CN 00100178 patent/CN1305816A/en active Pending
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102273621B (en) * | 2010-06-09 | 2015-07-29 | 苏州润新生物科技有限公司 | A kind of food of prevention and therapy diabetes or health food |
| CN102273621A (en) * | 2010-06-09 | 2011-12-14 | 苏州润新生物科技有限公司 | Food or health-care food for preventing and treating diabetes mellitus |
| CN103599381B (en) * | 2013-10-23 | 2015-09-30 | 陈维娜 | The Chinese medicine for the treatment of diabetes |
| CN103599381A (en) * | 2013-10-23 | 2014-02-26 | 陈维娜 | Traditional Chinese medicine for treating diabetes |
| CN103599383A (en) * | 2013-10-25 | 2014-02-26 | 李孔琳 | Traditional Chinese medicine formula for diabetes |
| CN103599382B (en) * | 2013-10-25 | 2015-09-30 | 陈维娜 | Treat the Chinese medicine for treating diabetes with fatty liver and hyperlipidemia intercurrent disease |
| CN103599382A (en) * | 2013-10-25 | 2014-02-26 | 陈维娜 | Traditional Chinese medicine for treating diabetes accompanied with fatty liver and hypertension complications |
| CN103599383B (en) * | 2013-10-25 | 2015-09-30 | 李孔琳 | Traditional Chinese medicine composition for treating diabetes |
| CN103599385A (en) * | 2013-10-28 | 2014-02-26 | 陈维娜 | Traditional Chinese medicinal composition for treating hyperglycemia |
| CN103599384B (en) * | 2013-10-28 | 2015-07-08 | 陈维娜 | Traditional Chinese medicinal preparation for treating hyperglycemia |
| CN103599385B (en) * | 2013-10-28 | 2015-08-19 | 陈维娜 | A kind of Chinese medicine composition for the treatment of hyperglycemia |
| CN103599384A (en) * | 2013-10-28 | 2014-02-26 | 陈维娜 | Traditional Chinese medicinal preparation for treating hyperglycemia |
| CN103599386A (en) * | 2013-10-28 | 2014-02-26 | 陈维娜 | Traditional Chinese medicinal composition for treating diabetes |
| CN103656076A (en) * | 2013-12-18 | 2014-03-26 | 南昌大学 | Probiotics and Chinese herbal medicine compound preparation with hypoglycemic function |
| CN103656076B (en) * | 2013-12-18 | 2016-04-13 | 南昌大学 | There is the probiotic bacteria-Chinese herbal medicine complex formulation of function of blood sugar reduction |
| CN104740085A (en) * | 2015-04-19 | 2015-07-01 | 王跃进 | Method for producing blood glucose-reducing soft capsules by use of large dosage of dried rehamnnia root |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101274044A (en) | Medicament for preventing and treating fatty liver and method of preparing the same | |
| CN101062339A (en) | Medicine for treating diabetes | |
| CN1305816A (en) | Medicine for treating diabetes | |
| CN1123347C (en) | Chinese medicine for decreasing fat and lossing weight and preparation method thereof | |
| CN1160107C (en) | Weight-lossing hypolipemic medicine | |
| CN101406594B (en) | Chinese medicine for treating tumor of lung | |
| CN101850071B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843778B (en) | Chinese medicament for treating ichthyosis | |
| CN101843733B (en) | Chinese medicament for treating ichthyosis | |
| CN101537114B (en) | Chinese medicine for treating arrhythmia | |
| CN1814125A (en) | Rehmannia-root preparation | |
| CN102716359A (en) | Traditional Chinese patent medicine and traditional Chinese medicine decoction for effectively treating diarrhea | |
| CN1185959A (en) | Chinese medicine for chronic nephritis | |
| CN1263495C (en) | Mayiniaotang pill for treating glucose in urine and preparation method thereof | |
| CN101554445B (en) | Traditional Chinese medicine for treating diabetic hyperlipemia | |
| CN101554426B (en) | Traditional Chinese medicine for treating diabetic obstipation | |
| CN101978989A (en) | Chinese medicament for treating diabetic diarrhea | |
| CN101884747B (en) | Traditional Chinese medicine for treating chronic nephritis | |
| CN101637565A (en) | Pure Chinese medicinal preparation for treating arrhythmia | |
| CN101843745B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843844B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101879259B (en) | Traditional Chinese medicine for treating pulmonary heart diseases | |
| CN101530501B (en) | Traditional Chinese medicine for treating diabetic anemia | |
| CN101843771B (en) | Chinese medicament for treating ichthyosis | |
| CN1313118A (en) | Hypoglycemic capsule |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |